MRK · Merck & Co., Inc.
AI read · Good for MRK
The AI's read
The ruling removes an immediate legal barrier to Merck offering Keytruda SC in Germany. That gives Merck a chance to pursue sales there, but the patent case is still ongoing.
The court removed the order that had stopped Merck from offering Keytruda SC in Germany. This gives Merck a chance to pursue sales there, though the patent case continues.
The ruling removes an immediate legal barrier to Merck offering Keytruda SC in Germany. That gives Merck a chance to pursue sales there, but the patent case is still ongoing.
The ruling removes the order that had stopped Merck from offering Keytruda SC in Germany, weakening Halozyme's immediate legal barrier. Halozyme's patent case is still ongoing.
Follow Merck & Co., Inc. (MRK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MRK